EPS for Axon Enterprise, Inc. (AAXN) Expected At $0.04

July 14, 2018 - By Robert Reynolds

Analysts expect Axon Enterprise, Inc. (NASDAQ:AAXN) to report $0.04 EPS on August, 14.They anticipate $0.00 EPS change or 0.00 % from last quarter’s $0.04 EPS. AAXN’s profit would be $2.33 million giving it 423.69 P/E if the $0.04 EPS is correct. After having $0.24 EPS previously, Axon Enterprise, Inc.’s analysts see -83.33 % EPS growth. The stock decreased 1.67% or $1.15 during the last trading session, reaching $67.79. About 627,763 shares traded. Axon Enterprise, Inc. (NASDAQ:AAXN) has risen 152.14% since July 14, 2017 and is uptrending. It has outperformed by 139.57% the S&P500.

Axon Enterprise, Inc. develops, manufactures, and sells conducted electrical weapons worldwide. The company has market cap of $3.95 billion. The firm operates through two divisions, TASER Weapons and Axon. It has a 269.01 P/E ratio. It offers TASER X26P and TASER X2 smart weapons for law enforcement; TASER C2 and TASER Pulse CEWs for the consumer market; and replacement cartridges.

More notable recent Axon Enterprise, Inc. (NASDAQ:AAXN) news were published by: Fool.com which released: “3 Stocks That Have Doubled and Still Have Room to Grow” on July 10, 2018, also Benzinga.com with their article: “Analyst: The Bullish Case For Axon Isn’t Based On Taser Sales Alone” published on July 02, 2018, Fool.com published: “Why Axon Enterprise Inc.’s Stock Is Up 154% in 2018” on July 10, 2018. More interesting news about Axon Enterprise, Inc. (NASDAQ:AAXN) were released by: Seekingalpha.com and their article: “Don’t Sell Axon Enterprise – Cramer’s Lightning Round (7/11/18)” published on July 12, 2018 as well as Bizjournals.com‘s news article titled: “Digital Ally’s patents cases against Taser, WatchGuard advance after surviving 5 challenges” with publication date: July 10, 2018.

Axon Enterprise, Inc. (NASDAQ:AAXN) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.